Navigation Links
JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
Date:7/5/2011

PARSIPPANY, N.J., July 5, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a leading marketer and manufacturer of sterile injectable products, is launching larger pack sizes for three products commonly used in acute care clinical settings: Adrenalin® (epinephrine injection, USP), Coly-Mycin® M Parenteral (colistimethate sodium, USP) and Pitocin® (oxytocin injection, USP synthetic).

Stuart Hinchen, CEO and President of JHP noted, "The larger pack size was developed to meet customer demand for cost savings and increased pharmacy efficiency by reducing packaging waste.  Our new multipacks allow pharmacy staff to open one carton containing multiple vials rather than open multiple cartons containing only one vial.  The efficiency is critical in busy pharmacies handling high volume products such as Adrenalin®, Coly-Mycin® M and Pitocin® and the cost savings are significant."  

Commenting on JHP's philosophy of marketing mature brand name products at competitive prices, Hinchen stated, "JHP is focused on meeting three key customer needs: quality, price and supply.  Reducing packaging waste in high volume products is an example of how we stay price competitive without sacrificing quality.  We are also vigilant in our efforts to provide the market with a reliable drug supply.  Since we manufacture our products, we have the dexterity to adapt to changing market demand which is crucial in today's injectable market."

All three products are still available in single vial packs to meet the needs of smaller clinical settings.  For more information about these products or other JHP products, please visit www.jhppharma.com/jhppricing and contact your local wholesaler or distributor.Products Available in a New Multipack Size* NDCProductStrengthVial SizePackSizeLatexFree42023-101-10Adrenalin® Injection1mg/mL30mL MDV10Yes42023-107-06Coly-Mycin® M Parenteral 150mg colistin base10mL SDV6Yes42023-116-02Pitocin® 10 units/mL10mL MDV25Yes*See full prescribing information for JHP products at http://www.jhppharma.com/products/About JHP Pharmaceuticals, LLC - JHP Pharmaceuticals, headquartered in New Jersey, is an integrated specialty healthcare company that acquires, develops, manufactures and sells sterile injectable products.  JHP markets 15 well-established branded pharmaceutical products primarily into the hospital segment.  JHP provides customers with a reliable supply of brand name products at competitive prices. 

JHP employs more than 330 staff in the USA in its manufacturing, product development, sales & marketing and corporate areas.  For more information, please visit www.jhppharma.com.

Contact:JHP Customer Service Tel: 1-877-547-4547MK246B
'/>"/>

SOURCE JHP Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):